Dev.ADA

BIBLIOGRAPHY

  1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders IV. Washington, DC: American Psychiatric Association, 1994.
  2. Barkley RA. A review of stimulant drug research with hyperactive children. J Child Psychol Psych 1977; 18:137-65.
  3. Bradley C. The behavior of children receiving benzedrine. 1937; Amer J Psych 94:577-585.
  4. Shaywitz BA, Yager RD, Klopper JH. Selective brain dopamine depletion in developing rats: An experimental model of minimal brain dysfuntion. Science 1976; 191:305-308.
  5. Fuller RW, Perry KW, Bymaster FP, Wong DT. Comparative effects of pemoline, amfonelic acid and amphetamine on dopamine uptake and release in vitro and on brain 3,4-dihydroxyphenylacetic acid concentration on spiperone treated rats. J Pharm Pharmocol 1978; 30:197-198.
  6. Kuczenski R. Biochemical actions of amphetamine and other stimulants. Neurochemical, behavioral and clinical perspectives ed. I. New York, NY: Raven Press, 1983.
  7. Langer DH, Rapoport JL, Brown GL, et al. Behavioral effects of carbidopa/levodopa in hyperactive boys. J Amer Acad Child Adol Psychiat 1982; 21:10-18.
  8. Winsburg, BG, Yerpes LE. Antipsychotics (major tranquilizers, neuroleptics). In Pediatric Psychopharmacology: The use of behavior modifying drugs in children, ed. JS Werry. New York, Brunner/Mazel 1978; pp234-274.
  9. Blackman JA, Samson-Fang L, Gutgesell H. Conidine and electrocardiograms (letter to the editor). Pediatrics 1996; 98(6):1223-4.
  10. Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Amer Acad Child Adol Psychiat 1985 ;24:617-629.
  11. Brown GL, Ebert MH, Hunt RD. Urinary 3-methoxy-4-hydroxyphenylglycol and homovanillic acid response to d-amphetamine in hyperactive children. Biol Psychiat 1981; 16:779-787.
  12. Shekim WO, DeKirmenjian H, Chapel JL. Urinary catecholamine metabolites in hyperactivity: A pilot study. Amer J Psychiat 1982; 139:936-938
  13. Shekim WO, Javaid J, Dekirmenjian H, et al. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys. Amer J Psychiat 1982; 139(4):485-8.
  14. Zametkin AJ, Karoum F, Rapoport JL, et al. Phenylethylamine excretion in attention deficit disorder. J Amer Acad Child Adol Psychiat 1984; 23:310-314.
  15. Donnelly M, Zametkin AJ, Rapoport JL et al.Treatment of hyperactivity with desipramine: plasma drug concentration, cardiovascular effect, plasma and urinary catecholamine levels, and clinical response. Clin Pharm 1986; 39:72-81.
  16. Zametkin AJ, Rapoport JL. Neurobiology of attention deficit disorder with hyperactivy: where have we come in 50 years? J Amer Acad Child Adol Psychiat 1987; 26(5):676-686.
  17. Bunney BS, Walters JR, Kohar MJ, et al. D and L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons. Psychopharm Comm 1975; 1:177-190.
  18. Goldberg LI, Volkman PH, Kohli JD. A comparison of the vascular dopamine receptor with other dopamine receptors. Ann Rev Pharmacol Toxicol 1978; 18:57-79.
  19. Halaris AE, Belendiuk KT, Freedman DX. Antidepressant drugs affect dopamine uptake. Biochem Pharmacol 1975; 24:1896-1897.
  20. Nurse B, Russell VA, Taljaard JJ. Effect of chronic desipramine treatment on adrenoceptor modulation of [3H]dopamine release from rat nucleus accumbens slices. Brain Res 1985; 334:235-242.
  21. Potter WZ, Scheinin M, Golden RN, et al. Selective antidepressants lack specificity on norepinephrine and serotonin metabolites in cerebrospinal fluid. Arch Gen Psychiat 1985; 42:1171-1177.
  22. Garfinkle BD, Wender PH, Sloman L, Oneill I. Tricyclic antidepressants and methylphenidate treatment of attention deficit disorder in children. J Amer Acad Child Adol Psych 1983; 22:343-348.
  23. Biederman J, Faraone SV, Keenan K, et al. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1990; 29(4):526-533.
  24. Goodman R, Stevenson J. A twin study of hyperactivity - II. The aetiological role of genes, family relationships and perinatal adversity. J Child Psychol Psychiat 1989; 30:691-709.
  25. ADD Spectrum Neurological 1993
  26. Zametkin AJ, Nordahl TE, Gros M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. NEJM 1990; 323(20):1361-6.
  27. Lou HC, Henriksen L, Bruhn P, et al. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 1989; 46:48-52.
  28. Hynd GW, Hern KL, Novey ES, et al. Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus. Journal of Child Neurology 1993; 8(4):339-347.
  29. Singer HS, Reiss AL, Brown JE, et al. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 1981; 43:950-956.
  30. Heilman KM, Bowers D, Valenstein E, Watson RT. The right hemisphere neuropsychological functions. J Neurosurg 1986; 64:693-704.
  31. Heilman KM, Voeller KK, Nadeau SE. A possible pathophysiologic substate of attention deficit hyperactivity disorder. J Child Neuro 1991; 6(suppl):S76-S81.
  32. Mesulam MM. Frontal cortex and behavior. Ann Neurol 1986; 19:320-5.
  33. Chelune GJ, Ferguson W, Koon R, Dickey TO. Frontal lobe disinhibition in attention deficit disorder. Child Psychiatry Hum Dev 1986; 16:221-34.
  34. Hunt RD, Hoehn R, Stephens KJ,et al. Clinical patterns of ADHD: A treatment model based on brain functioning. Comprehensive Therapy 1994; 20(2);106-112.
  35. Ottenbacher KJ, Cooper HM. Drug treatment of hyperactivity in children. Developmental Medicine and Child Neurology 1983; 25:358-366.
  36. Wolraich ML. Behavior modification therapy in hyperactive children: Research and clinical implications. Clinical Pediatrics 1979; 18:563-570.
  37. Stevenson RD, Wolraich ML. Stimulant medication therapy in treatment of children with attention deficiet hyperactivity disorder. Pediatric Clinics of North America 1989; 36:1183-1197.
  38. AAP Consensus Statement: Medication for children with an attention deficit disorder. Pediatrics 1987; 80:758-760.
  39. Croche AF, Lipman RS, Overall JE, Hung W. The effects of stimulant medication on the growth of hyperkinetic children. Pediatrics 1979; 63:847-850.
  40. Mcbride MC, Wang DD, Torres CF. Methylphenidate in therapeutic doses does not lower seizure threshold. Ann Neurol 1986; 20:428.
  41. Leckman JF, Detlor J, Harcherik DF, et al. Acute and chronic clonidine treatment in Tourette's syndrome: a preliminary report on clinical response and effect on plasma and urinary catecholamine metabolites, growth hormone, and blood pressure. J Amer Acad Child Psych 1983; 22:433-440.
  42. Denckla MB, Bemporad JR, Mackay MC. Tics following methyphenidate administration. A report of 20 cases. JAMA 1976; 235:1349-1351.
  43. Steingard R, Biederman J, Spencer T, et al. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and with out comorbid tic disorders. J American Acad Child Adolescent Psych 1993; 32:350-353.
  44. Mcbride MC. An individual double-blind crossover trial for assessing methylphenidate response in children with attention deficit disorder. J Pediatr 1988; 113:137-145.
  45. Wilens TE, Biederman J. The stimulants. Psych Clin North Am 1992; 15:191-222.
  46. Satterfield JH, Satterfield BT, Cantwell DP. Three-year multimodality treatment study of 100 hyperactive boys. J Pediatr 1981; 98(4):650-655.
  47. Famularo R, Fenton T. The effect of methylphenidate on school grades in children with attention deficit disorder without hyperactivity: a preliminary report. J Clin Psychiatry 1987; 48(3): 112-114.
  48. Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996; 35(4): 409-432.
  49. Connors CK. Feeding the Brain: How foods affect children. New York, NY: Plenum Press, 1989.
  50. Zametkin AJ, Liebenauer LL, Fitzgerald GA, et al. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Archives of General Psychiatry 1993; 50(5): 333-340.
  51. Gilman S, Newman SW. Essentials of Clinical Neuroanatomy and Neurophysiology. Philadelphia, PA: F.A. Davis Company, 1992.
Use BACK BUTTON to return to previous page.

Table of Contents